Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06556602
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Methadone Patient Access to Collaborative Treatment
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Methadone Patient Access to Collaborative Treatment MPACT
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MPACT
Brief Summary:
The trial of Methadone Patient Access to Collaborative Treatment MPACT will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose
It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation
It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation
Detailed Description:
This MPACT trial will involve finalizing the refined MPACT intervention materials training and conducting a Hybrid Type 1 15-month cluster randomized controlled trial in 30 clinics with 600 patients 20clinic and 480 staff 18clinic to assess MPACT effect on patient outcomes and examine the relationship between staff trauma outcomes and MPACT implementation R33 Specific AIMS
AIM 1 Quantify the effects of MPACT on methadone treatment MMT practice change and opioid treatment program OTP culture
AIM 2 Determine the efficacy of MPACT on MMT retention in-MMT overdose and patient and staff post traumatic stress symptoms PTSS outcomes
AIM 3 Evaluate the effect of patient and staff trauma symptoms on primary outcomes and staff MPACT implementation
AIM 1 Quantify the effects of MPACT on methadone treatment MMT practice change and opioid treatment program OTP culture
AIM 2 Determine the efficacy of MPACT on MMT retention in-MMT overdose and patient and staff post traumatic stress symptoms PTSS outcomes
AIM 3 Evaluate the effect of patient and staff trauma symptoms on primary outcomes and staff MPACT implementation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None